Building on this legacy, Albemarle has never rested on its laurels. In 2019, we will complete a 9,000 sq ft capacity expansion of our R&D facilities, creating vastly more space for our teams to work on our customer’s projects at lab scale and kilo lab. Our experience and state-of-the-art facilities and equipment will progress your drug substance faster and more efficiently than ever before, providing solutions to development challenges.
Tightly integrated teams
Our R&D and analytical teams at South Haven, Michigan and Tyrone, Pennsylvania are able to work together easily, and bring diverse collective knowledge across registered starting materials (RSMs), intermediates and active pharmaceutical ingredients (APIs).